Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
search-icon-img
Advertisement

SSI Innovations launches medical robotics surgery system in India

New Delhi, January 19 Medical robotic technology firm SS Innovations on Tuesday launched its SSI multi-arm novel tele-robotic assistance surgical system in the country at a price of Rs 4-5 crore. The company in a statement said that the dominant...
  • fb
  • twitter
  • whatsapp
  • whatsapp
Advertisement

New Delhi, January 19

Medical robotic technology firm SS Innovations on Tuesday launched its SSI multi-arm novel tele-robotic assistance surgical system in the country at a price of Rs 4-5 crore.

The company in a statement said that the dominant current robotic system is expensive and associated with a steep learning curve, resulting in the limited availability.

Advertisement

“The price of the system will be around Rs 4 to 5 crore. Initially, once we go into the commercial production we will be able to produce between 150-200 robotics systems in the first year. Our goal will be to ramp up the production as we launch our products globally,” SSI Chairman and CEO Sudhir P Srivastava said.

“Robotics shall be the future of surgery, and my vision is to create a technologically advanced system that will be cost-effective, easy to use, and can be applied to all surgical specialities. Thus, benefiting most patients around the world,” Srivastava said.

Advertisement

Compared to conventional surgery, robotic surgery results in smaller incisions, that reduces pain, scarring and leads to quicker recovery, he added.

The MANTRA (multi-arm novel tele robotic assistance) system was recently utilised for the first in human pilot study at Rajiv Gandhi Cancer Institute, where the surgeons successfully completed 18 complex Urology, Gynaecology and General Surgery procedures in less than a month, the statement said.

“The dedicated team of engineers and scientists at SS Innovations have been working hard under Dr Srivastava’s guidance for the past few years to develop a cost-effective robotic surgical system. I congratulate them on this launch”, Rajiv Gandhi Cancer Institute Medical Director Dr Sudhir Rawal said. — PTI

Advertisement
Advertisement
Advertisement
Advertisement
tlbr_img1 Home tlbr_img2 Opinion tlbr_img3 Classifieds tlbr_img4 Videos tlbr_img5 E-Paper